Article ID Journal Published Year Pages File Type
6055237 Oral Oncology 2013 5 Pages PDF
Abstract
When cisplatin is contraindicated, carboplatin-based CRT yields equivalent treatment outcomes in patients with LASCCHN.
Related Topics
Health Sciences Medicine and Dentistry Dentistry, Oral Surgery and Medicine
Authors
, , , , , , , , ,